Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) has a poor prognosis if left untreated but can be cured by pulmonary endarterectomy (PEA). Massive endobronchial pulmonary hemorrhage is a potentially fatal complication of PEA, occurring in 0.5%of patients. We describe the use of an endobronchial blocker (EBB) as an additional method to successfully treat massive, focal pulmonary hemorrhage during PEA.
Original languageEnglish
Pages (from-to)1130-1133
Number of pages4
JournalJournal of heart and lung transplantation
Volume41
Issue number8
Early online date2022
DOIs
Publication statusPublished - Aug 2022

Keywords

  • chronic thromboembolic pulmonary hypertension
  • endobronchial blocker
  • pulmonary endarterectomy
  • pulmonary hemorrhage
  • veno-arterial (VA)-ECMO

Fingerprint

Dive into the research topics of 'Endobronchial blocker use for massive, focal pulmonary hemorrhage during pulmonary endarterectomy for CTEPH'. Together they form a unique fingerprint.

Cite this